key: cord-0807007-6cgajmb8
authors: Bonanad, Clara; García-Blas, Sergio; Tarazona-Santabalbina, Francisco; Sanchis, Juan; Bertomeu-González, Vicente; Fácila, Lorenzo; Ariza, Albert; Núñez, Julio; Cordero, Alberto
title: The effect of age on mortality in patients with Covid-19: a metanalysis with 611,583 subjects
date: 2020-05-25
journal: J Am Med Dir Assoc
DOI: 10.1016/j.jamda.2020.05.045
sha: 0e65f9a7a5541fc0da7076ea9a6114f045fd3267
doc_id: 807007
cord_uid: 6cgajmb8

ABSTRACT Objectives Initial data on Covid-19 infection has pointed out a special vulnerability of elderly people. Design we performed a meta-analysis with available national reports at May 7th 2020 from China, Italy, Spain, United Kingdom and New York State. Analyses were performed by a random effects model and sensitivity analyses were performed for the identification of potential sources of heterogeneity. Setting and Participants: covid-19 positive patients reported in literature and national reports. Measures all-cause mortality by age. Results A total of 611,1583 subjects were analyzed and 141,745 (23.2%) had age ≥80. The percentage of octogenarians was different in the 5 registries being the lowest in China (3.2%) and the highest and the highest in UK and New York State. The overall mortality rate was 12.10% and it varied widely between countries being the lowest in China (3.1%) and the highest in UK (20.8%) and New York State (20.99%). Mortality was <1.1% in patients with age <50 and it increased exponentially after that age in the 5 national registries. As expected, the highest mortality rate was observed in patients ≥80 years old. All age groups had significantly higher mortality compared to the inmediatelly younger age group. The largest increase in mortality risk was observed in patients with age 60-69 compared to 50-59 (OR: 3.13 95% CI 2.61-3.76). Conclusions and implications this metanalysis with more than half-million of Covid-19 patients from different countries highlights the determinant effect of age on mortality with the relevant thresholds on age >50 and, especially, >60. Elderly patients should be priorized in the implementation of preventive measures.

Measures: all-cause mortality by age. 10

Results: A total of 611,1583 subjects were analyzed and 141,745 (23.2%) had 11 age ≥80. The percentage of octogenarians was different in the 5 registries 12 being the lowest in China (3.2%) and the highest and the highest in UK and 13

New York State. The overall mortality rate was 12.10% and it varied widely 14 between countries being the lowest in China (3.1%) and the highest in UK 15 (20.8%) and New York State (20.99%). Mortality was <1.1% in patients with 16 age <50 and it increased exponentially after that age in the 5 national 17 registries. As expected, the highest mortality rate was observed in patients 18 ≥80 years old. All age groups had significantly higher mortality compared to 19 the inmediatelly younger age group. The largest increase in mortality risk was 20 observed in patients with age 60-69 compared to 50-59 (OR: 3.13 95% CI 21 2.61-3.76). 22

Conclusions and implications: this metanalysis with more than half-million of 23 as by the end of February 2020 it had become a pandemic and a public health 35 emergency worldwide 1 . Clinical severity of the infection ranges from 36 asymptomatic or mildly symptomatic patients to critical situation with bilateral 37 pneumonia leading to multiorgan failure 2 and, therefore, it is essential to 38 identify prognostic factors related to more severe forms of the disease and 39

Initial data has pointed out a special vulnerability of elderly people. Case 41 series have identified age as an independent prognostic factor for mortality 3 . 42 Also, national registries have shown a high mortality rate among patients over 43 80 years old 4-6 . Therefore, elderly people seem to have a higher proportion of 44 severe cases of COVID-19 and fatal outcome. The present study aims to 45 analyze the available data of mortality in the elderly population compared to 46 its younger counterparts. 47 48 49

We performed a systematic search (using PUBMED, EMBASE, and 51

Cochrane Central Register of Controlled Trials (CENTRAL), and Google 52 Scholar), without language restriction, for papers using the Medical Subject 53

Headings terms "Coronavirus," "Covid-19", "Mortality, "Clinical outcomes" and 54 "Clinical course" up to May 7 th 2020. We also searched for national reports in 55 the official Health Services´ website of all European Countries. Primary 56 outcome was all cause-death. As a result 17 studies that reported clinical 57 features of patients who died vs. survivors: most were hospital registries 3, 7-9 , 4 58 were national reports (from China 4 , Italy 5 , and Spain 6 and United 59

Kingdom(UK) 10 ) and 1 was a publication from Northwell Health, the largest 60 academic health system in New York State 11 . Hospital registries did not 61 include age distribution and, therefore, could not be included. Elderly patients 62

were defined as those 80 years of age or older Reviews and Meta-Analyses (PRISMA) Statement 12 . Clinical features and 66 mortality rates were available in all studies. Relative risk reductions and 67 percent incidences were used. The study-specific standard errors for the 68 estimated odds ratio were used to model the within-study variation. The 69

percentage of variability across studies attributable to heterogeneity beyond 70 chance was estimated using the I 2 statistic. Once heterogeneity was observed 71 and assuming that the study effect sizes were different as well as that the 72 collected studies represented a random sample from a larger population, all 73 the analyses were performed by a random effects model. Sensitivity analyses 74

were performed for the identification of potential sources of heterogeneity 75 between studies with meta-regression analyses and the Harbord test, to 76 assess the small-study effects 13 . All analyses were performed using STATA State. The overall mortality rate was 12.10% and it varied widely between 86 countries being the lowest in China and the highest in UK and New York 87

According to age, mortality was <1% in patients with age <50 and it 89 increased exponentially after that age (figure 1). As expected, the highest 90 mortality rate was observed in patients ≥80 years old. All age groups had 91 significantly higher mortality compared to the inmediatelly younger age group 92 (figure 2). The largest increase in mortality risk was observed in patients with 93 age 60-69 compared to 50-59. Patients with age >80 had 60% higher risk of 94 dead compared to patients with age 70-79 but it was 6-fold higher (OR: 6.25

Significant heterogeneity (p<0.001) was observed and, the funnel plot 97 (figure 2). Metaregression identified sample size (p=0.002), countries 98 (p=0.001) and mean age (p=0.001) as significant sources of heterogeneity; 99 the small-effect study was also observed (Harbor test p=0.013). 100 101 102

The metanalysis of currently available national and regional reports of Since the start of the pandemic, age has been outlined as key prognosis 108 determinant in Covid-19 patients. Based on the early statistical data of China, 109 the case-fatality rate (CRF) increases markedly from the age of 60, reaching 110 14.8% in those over 80 14 . Initial data from Italian patients also described that 111 mortality increased significantly in septuagenarian patients and almost tripled 112 in octogenarians 15 . In a Chinese cohort study, age was identified as an 113 independent predictor of mortality, with an Odds Ratio = 1.1 (95% CI 1.03-114 1.17) for each year 3 . Our analysis of 611,583 patients shows a mortality 115 increase related to age; this is evident in patients ≥60 years, increasing 116 significantly in each decade of life. Therefore, the highest mortality occurs in 117 the patients ≥80 in whom it was 6-times higher than in younger patients. 118

These findings are consistent with a higher susceptibility to the infection 119 and severe clinical manifestations observed in elderly of patients 3, 16 . This fact 120 could be influenced by both the physiological aging process and, especially, 121 the greater prevalence in elderly patients of frailty and comorbidities that 122 contribute to a decrease in functional reserve that reduces intrinsic capacity 123 and resilience and hinders the fight against infections 17 

The metanalysis of currently available data suggest a determinant effect 142 of age in mortality of Covid-19 patients with a relevant threshold on age >50 143 and especially >60. Nevertheless, more clinical and basic research is needed 144 to elucidate the mechanism involved in the COVID-19 infection in elderly 145 patients and to develop strategies to improve outcomes in these patients. 

Coronavirus disease (COVID-19) outbreak

Characteristics of and Important Lessons 168

From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: 169 Summary of a Report of 72 314 Cases From the Chinese Center for Disease 170

Control and Prevention

Clinical course and risk factors for mortality 172 of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort 173 study. The Lancet 2020

Vital Surveillances: The Epidemiological Characteristics of an 177

Novel Coronavirus Diseases (COVID-19) -China, 2020. 178 2020. 179 5. Task force COVID-19 del Dipartimento Malattie Infettive e Servizio di

Aggiornamento nazionale: 7 maggio

Informe sobre la situación de COVID-19 en España

COVID-19) infection: a systematic review and meta-188 analysis

Clinical predictors of mortality due to 191

COVID-19 based on an analysis of data of 150 patients from

Clinical characteristics of 113 deceased 10. UK-HNS. National COVID-19 weekly summary report

Hospitalized With COVID-19 in the New York City Area

Improving the quality of reports 204 of meta-analyses of randomised controlled trials: the QUOROM statement

Quality of Reporting of Meta-analyses

Recommendations for 207 examining and interpreting funnel plot asymmetry in meta-analyses of 208 randomised controlled trials

Similarity in Case Fatality Rates 212 (CFR) of COVID-19/SARS-COV-2 in Italy and China

Clinical features of patients infected with 215 2019 novel coronavirus in Wuhan, China

Coronavirus: la emergencia geriátrica de 2020. Documento conjunto de la 219

Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología y 220

Cardiología 2020

The Dilemma of Coronavirus 223 Disease 2019, Aging, and Cardiovascular Disease: Insights From 224 Cardiovascular Aging Science